Third Rock Ventures II, L.P.

10% owner at MyoKardia Inc; 10% owner at Global Blood Therapeutics, Inc.

Sold, on record
$47.9M
Dollars the filings state
Form 4 sales
2
Latest Sep 11, 2017
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Global Blood Therapeutics, Inc.Unusual
    Nov 14, 2016 2016

    Sold 2M shares at $19.36 ($38.7M)

    Third Rock Ventures II, L.P., 10% owner

    Sold 60.9% of holdings ($63.6M position)1.3M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale MyoKardia IncUnusual
    Sep 11, 2017 +301 days

    Sold 221,250 shares at $41.30 ($9.1M)

    Third Rock Ventures II, L.P., 10% owner

    Sold 79.3% of holdings ($11.5M position)57,651 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Third Rock Ventures II, L.P.
Source
Sep 11, 2017Sep 12, 2017MyoKardia Inc10% ownerForm 4 sale221,250$9.1M79.3%UnusualSEC
Nov 14, 2016Nov 16, 2016Global Blood Therapeutics, Inc.10% ownerForm 4 sale2M$38.7M60.9%UnusualSEC